GoodRx Holdings, Inc.(GDRX) Stock Research - Grey Stern Research
Loading...

GoodRx Holdings, Inc. (GDRX) Stock Analysis

$4.89 (0.00%)

GDRX Financial Performance


Use the table below to view GoodRx Holdings, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $4.89 -
52 Week Low $4.63 -
52 Week High $9.26 -
Market Cap $1.9 Billion 5/18
Gross Margin 86% 3/18
Profit Margin 3% 6/18
EBITDA margin 19% 5/18
Q2 - 2024 Revenue $200.6 Million 6/18
Q2 - 2024 Earnings $6.7 Million 4/18
Q2 - 2024 Free Cash Flow -$7.5 Million 14/18
Trailing 4 Quarters Revenue $775.1 Million 6/18
Trailing 4 Quarters Earnings -$58.7 Million 9/18
Quarterly Earnings Growth -89% 15/18
Annual Earnings Growth -220% 15/18
Quarterly Revenue Growth 6% 9/18
Annual Revenue Growth 5% 10/18
Cash On Hand $524.9 Million 3/18
Short Term Debt $12.4 Million 6/18
Long Term Debt $645.6 Million 3/18

GoodRx Holdings, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare GoodRx Holdings, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 7/18
PS 2.39 9/18
PB 2.77 10/18
PC 3.53 14/18
Liabilities to Equity 1.20 4/18
ROA -0.04 8/18
ROE -0.09 10/18
Current Ratio 1.83 15/18
Quick Ratio 0.65 11/18
Long Term Debt to Equity 0.96 2/18
Debt to Equity 1.06 1/18
Burn Rate 23.61 2/18
Cash to Cap 0.28 5/18
CCR -1.12 14/18
EV to EBITDA 54.23 9/18
EV to Revenue 2.63 8/18

Company Details

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.

CEO: Mr. Douglas J. Hirsch

Website: https://www.goodrx.com

Address: 233 Wilshire Boulevard Santa Monica, CA

Exchange: NASDAQ Global Select

Industry: Health Information Services

GoodRx Holdings, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to GoodRx Holdings, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Veeva Systems Inc. VEEV $38.4 Billion
Evolent Health, Inc. EVH $1.8 Billion
Teladoc Health, Inc. TDOC $1.7 Billion
HealthStream, Inc. HSTM $989.7 Million
Health Catalyst, Inc. HCAT $506.3 Million
National Research Corporation NRC $508.2 Million
NextGen Healthcare, Inc. NXGN $1.6 Billion
Progyny, Inc. PGNY $1.5 Billion
10x Genomics, Inc. TXG $1.9 Billion
Schrödinger, Inc. SDGR $1.4 Billion
Accolade, Inc. ACCD $294.8 Million
American Well Corporation AMWL $138.8 Million
Certara, Inc. CERT $1.8 Billion
Privia Health Group, Inc. PRVA $2.7 Billion
Doximity, Inc. DOCS $11.4 Billion
Definitive Healthcare Corp. DH $515.3 Million
Talkspace, Inc. TALK $586.2 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
GDRX Income Statements
Quarter Year Revenue Earnings
Q2 2024 $ 200.6 Million $6.7 Million
Q1 2024 $ 197.9 Million -$1.0 Million
Q4 2023 $ 196.6 Million -$25.9 Million
Q3 2023 $ 180.0 Million -$38.5 Million
Q2 2023 $ 189.7 Million $58.8 Million
Q1 2023 $ 184.0 Million -$3.3 Million
Q4 2022 $ 184.1 Million -$2.0 Million
Q3 2022 $ 187.3 Million -$41.7 Million

View All

GDRX Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 $524.9 Million $1.5 Billion $707.4 Million $669.4 Million
Q1 2024 $533.3 Million $1.5 Billion $710.2 Million $631.1 Million
Q4 2023 $672.3 Million $1.6 Billion $63.4 Million $762.0 Million
Q3 2023 $794.9 Million $1.7 Billion $711.5 Million $881.3 Million
Q2 2023 $762.0 Million $1.7 Billion $714.4 Million $895.4 Million
Q1 2023 $761.1 Million $1.6 Billion $715.9 Million $827.5 Million
Q4 2022 $757.2 Million $1.6 Billion $717.0 Million $814.8 Million
Q3 2022 $728.8 Million $1.6 Billion $45.6 Million $788.4 Million

View All

GDRX Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 -$7.5 Million -$17.2 Million -$8.4 Million
Q1 2024 $22.0 Million -$20.6 Million -$139.0 Million
Q4 2023 $11.4 Million $0 $11.4 Million
Q3 2023 $46.6 Million -$13.6 Million $32.9 Million
Q2 2023 $14.9 Million -$15.0 Million $913,000
Q1 2023 $18.0 Million -$14.3 Million $3.9 Million
Q4 2022 $16.6 Million -$15.3 Million $28.4 Million
Q3 2022 $20.0 Million -$13.8 Million -$1.8 Million

View All